Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics (Q43720103)

26 November 2017

title

Benzodiazepines: a major component in unintentional prescription drug overdoses with opioid analgesics (English)

1 reference

26 November 2017

0 references

1 reference

Michael Jann

1 reference

26 November 2017

William Klugh Kennedy

series ordinal

1 reference

26 November 2017

Gaylord Lopez

series ordinal

1 reference

26 November 2017

publication date

1 February 2014

1 reference

Journal of Pharmacy Practice

26 November 2017

published in

1 reference

26 November 2017

1 reference

26 November 2017

1 reference

26 November 2017

page(s)

5-16

1 reference

A National Epidemic of Unintentional Prescription Opioid Overdose Deaths: How Physicians Can Help Control It

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Polydrug abuse: a review of opioid and benzodiazepine combination use

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Patterns of abuse among unintentional pharmaceutical overdose fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Fatal poisonings in Oslo: a one-year observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Benzodiazepine Poisoning Clinical and Pharmacological Considerations and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Toxicological interactions between alcohol and benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

2008 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th Annual Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Unintentional prescription drug overdose deaths in New Mexico, 1994-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Acute overdosage with benzodiazepine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Rapid recovery from massive diazepam overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Plasma diazepam and desmethyldiazepam concentrations during long-term diazepam therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Benzodiazepine overdosage: plasma concentrations and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Pharmacogenetics of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Glucuronidation of dihydrocodeine by human liver microsomes and the effect of inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Benzodiazepines and alcohol are associated with cases of fatal buprenorphine poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Effects of Alcohol on the Pharmacokinetics of Morphine Sulfate and Naltrexone Hydrochloride Extended Release Capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Clinical experience with the benzodiazepine antagonist flumazenil in suspected benzodiazepine or ethanol poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Benzodiazepine use among rural prescription opioids users in a community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Declining benzodiazepine use in veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Prescribing trends in veterans with posttraumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Prevalence and trends of benzodiazepine use among Veterans Affairs patients with posttraumatic stress disorder, 2003-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Benzodiazepines, posttraumatic stress disorder, and veterans: good news and why we're not done yet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

A systematic review of research examining benzodiazepine-related mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Relative toxicity of benzodiazepines in overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Alprazolam is relatively more toxic than other benzodiazepines in overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

An analysis of the number of multiple prescribers for opioids utilizing data from the California Prescription Monitoring Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Prevalence and determinants of pharmacy shopping behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Doctor and pharmacy shopping for controlled substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Time series analysis of California's prescription monitoring program: impact on prescribing and multiple provider episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

The intended and unintended consequences of benzodiazepine monitoring programmes: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Appropriate Use and Regulatory Control of Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Prescription drug laws, drug overdoses, and drug sales in New York and Pennsylvania

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

The prescription drug epidemic in the United States: A perfect storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Utilization, spending, and price trends for benzodiazepines in the US Medicaid program: 1991-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Economic impact of potential drug–drug interactions in opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

Medication reconciliation for controlled substances--an "ideal" prescription-drug monitoring program

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0897190013515001

21 January 2018

Identifiers

DOI

10.1177/0897190013515001

1 reference

26 November 2017

1 reference